Literature DB >> 19453651

Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions.

P Valent1, H-P Horny.   

Abstract

Although a classification for myelodysplastic syndromes (MDS) has been proposed by several working groups and by the World Health Organization (WHO), with criteria useful to discriminate between disease variants, the important issue of minimal diagnostic criteria of MDS has only recently been addressed. In the current article, proposed minimal diagnostic criteria for MDS are discussed together with two conditions that do not meet these criteria, although cytopenia or dysplasia is present. These two conditions, idiopathic cytopenia of unknown significance and idiopathic dysplasia of unknown significance should be kept in mind as a provisional (potential) diagnosis in patients with suspected MDS. Both conditions can progress to frank MDS over time. Therefore, once diagnosed, these patients should have a haematological follow-up. The diagnosis MDS, on the other hand, needs to be based on robust criteria and exclusion of all other causes of cytopenia and dysplasia, which requires detailed and sometimes extensive investigations, including a bone marrow biopsy, cytogenetic analyses, molecular studies and flow cytometry.

Entities:  

Mesh:

Year:  2009        PMID: 19453651     DOI: 10.1111/j.1365-2362.2009.02151.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  21 in total

1.  Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors.

Authors:  Stefani Parmentier; Johannes Schetelig; Kerstin Lorenz; Michael Kramer; Robin Ireland; Ulrich Schuler; Rainer Ordemann; Gabi Rall; Markus Schaich; Martin Bornhäuser; Gerhard Ehninger; Frank Kroschinsky
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

2.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.

Authors:  David P Steensma; Rafael Bejar; Siddhartha Jaiswal; R Coleman Lindsley; Mikkael A Sekeres; Robert P Hasserjian; Benjamin L Ebert
Journal:  Blood       Date:  2015-04-30       Impact factor: 22.113

3.  Anaemia with inflammation responding to lenalidomide.

Authors:  Faysal Haroun; Andrew Mener; Jacob Elkon; Imad Tabbara
Journal:  BMJ Case Rep       Date:  2016-10-13

4.  Clinical utility of the neutrophil distribution pattern obtained using the CELL-DYN SAPPHIRE hematology analyzer for the diagnosis of myelodysplastic syndrome.

Authors:  Tohru Inaba; Yoichi Yuki; Soichi Yuasa; Naohisa Fujita; Kazue Yoshitomi; Toshinori Kamisako; Kunio Torii; Toshiharu Okada; Yoshimasa Urasaki; Takanori Ueda; Kaoru Tohyama
Journal:  Int J Hematol       Date:  2011-07-06       Impact factor: 2.490

5.  Idiopathic bone marrow dysplasia of unknown significance (IDUS): definition, pathogenesis, follow up, and prognosis.

Authors:  Peter Valent; Eva Jäger; Gerlinde Mitterbauer-Hohendanner; Leonhard Müllauer; Ilse Schwarzinger; Wolfgang R Sperr; Renate Thalhammer; Friedrich Wimazal
Journal:  Am J Cancer Res       Date:  2010-03-16       Impact factor: 6.166

Review 6.  The Clinical Challenge of Idiopathic Cytopenias of Undetermined Significance (ICUS) and Clonal Cytopenias of Undetermined Significance (CCUS).

Authors:  David P Steensma
Journal:  Curr Hematol Malig Rep       Date:  2019-12       Impact factor: 3.952

Review 7.  Nuances of Morphology in Myelodysplastic Diseases in the Age of Molecular Diagnostics.

Authors:  Aaron C Shaver; Adam C Seegmiller
Journal:  Curr Hematol Malig Rep       Date:  2017-10       Impact factor: 3.952

Review 8.  Assessing clonal haematopoiesis: clinical burdens and benefits of diagnosing myelodysplastic syndrome precursor states.

Authors:  Lukasz P Gondek; Amy E DeZern
Journal:  Lancet Haematol       Date:  2019-12-03       Impact factor: 18.959

Review 9.  Dysplasia has A differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors.

Authors:  David P Steensma
Journal:  Curr Hematol Malig Rep       Date:  2012-12       Impact factor: 3.952

10.  Distinguishing immunorelated haemocytopenia from idiopathic cytopenia of undetermined significance (ICUS): a bone marrow abnormality mediated by autoantibodies.

Authors:  R Fu; H Liu; Y Wang; H Liu; H He; J Chen; H Wang; H Yu; K Ding; L Huang; H Wang; L Xing; J Song; L Li; Z Shao
Journal:  Clin Exp Immunol       Date:  2014-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.